Rexahn Pharmaceuticals Inc (NYSE American:RNN)

1.60
Delayed Data
As of 8:00pm ET
 +0.05 / +3.23%
Today’s Change
1.42
Today|||52-Week Range
4.84
-20.79%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
AssetsCash9.8M10.2M11.6M8.9M
 
 
 
 
 
Short Term Investment Cash-8.9M373.2K1.4M-2.7M
 
 
 
 
 
Cash & Short Term Investments32.7M23.4M20.3M26.8M
 
 
 
 
 
 
ReceivablesReceivables0.000.000.000.00--
 
InventoriesInventories0.000.000.000.00--
 
Current AssetsPrepaid Expenses--501.2K179.5K--
 
 
 
Other Current Assets731.0K720.6K429.0K1.3M
 
 
 
 
 
Current Assets33.4M24.7M20.9M28.1M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross687.2K749.5K758.1K833.3K
 
 
 
 
 
Depreciation-609.1K-636.6K-669.5K-711.8K
 
 
 
 
 
Other Assets0.000.0030.8K30.8K
 
 
 
Total Assets33.5M24.8M21.0M28.3M
 
 
 
 
 
 
LiabilitiesAccounts Payable706.8K774.5K0.000.00
 
 
 
Accrued Expenses1.1M1.6M641.1K2.4M
 
 
 
 
 
Other Current Liabilities1.1M1.6M1.1M2.4M
 
 
 
 
 
Other Liabilities2.5M2.7M1.9M3.2M
 
 
 
 
 
 
Total LiabilitiesOther Liabilities3.9M2.8M1.7M7.9M
 
 
 
 
 
Total Liabilities7.0M6.0M4.0M11.5M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.000.00--
Common Equity26.6M18.8M17.1M16.8M
 
 
 
 
 
Total Shareholder Equity26.6M18.8M17.1M16.8M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding17.8M19.7M23.7M31.7M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.